Sheng Wang

4PUBLICATIONS
29CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyMedical biochemistry - lipidsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 05, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Jun 17, 2025
Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity.

Sheng Wang, Nicolas P F Barthes, Sylvia Urban

|Jan 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth.

Yanhan Jia, Sheng Wang, Sylvia Urban

|Jan 03, 2024
Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity.

Sheng Wang, Sebastian O Klein, Sylvia Urban

Pageof 1

Frequent Collaborators

3 joint publications

Manfred Jung

2 joint publications

Nicolas P F Barthes

2 joint publications

Eric Metzger

2 joint publications

Roland Schüle